Get the Stockscreener App
15.60
0.57%
-0.09
After Hours:
15.61
0.010
+0.06%
Bausch Lomb Corp stock is traded at $15.60, with a volume of 434.81K.
It is down -0.57% in the last 24 hours and up +3.11% over the past month.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
See More
Previous Close:
$15.69
Open:
$15.58
24h Volume:
434.81K
Relative Volume:
0.84
Market Cap:
$5.52B
Revenue:
$4.89B
Net Income/Loss:
$-263.00M
P/E Ratio:
-20.17
EPS:
-0.7734
Net Cash Flow:
$-167.84M
1W Performance:
+0.32%
1M Performance:
+3.11%
6M Performance:
+35.06%
1Y Performance:
-20.29%
1-Day Range:
$15.24
$15.87
1-Week Range:
$15.24
$16.81
52-Week Range:
$10.45
$20.71
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb Corp
Sector
Industry
Phone
908-541-5456
Address
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.60 | 5.56B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | Goldman | Neutral |
| May-02-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-15-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-10-24 | Initiated | Raymond James | Outperform |
| May-06-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-12-23 | Initiated | Stifel | Hold |
| Oct-03-23 | Resumed | Evercore ISI | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-09-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Sep-12-22 | Initiated | H.C. Wainwright | Buy |
| Jul-26-22 | Initiated | RBC Capital Mkts | Outperform |
| Jun-24-22 | Initiated | Evercore ISI | Outperform |
| Jun-06-22 | Initiated | Citigroup | Buy |
| May-31-22 | Initiated | Deutsche Bank | Hold |
| May-31-22 | Initiated | Goldman | Neutral |
| May-31-22 | Initiated | Guggenheim | Buy |
| May-31-22 | Initiated | JP Morgan | Neutral |
| May-31-22 | Initiated | Jefferies | Buy |
| May-31-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-31-22 | Initiated | Wells Fargo | Overweight |
| May-11-22 | Initiated | Cowen | Outperform |
View All
Bausch Lomb Corp Stock (BLCO) Latest News
Can Bausch + Lomb Corporation (S2L) stock sustain double digit ROE2025 Top Gainers & Daily Price Action Insights - newser.com
Real time breakdown of Bausch + Lomb Corporation stock performance2025 Retail Activity & High Accuracy Trade Signal Alerts - newser.com
(BLCO) Stock Market Analysis (BLCO:CA) - news.stocktradersdaily.com
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $17 to $17 - 富途牛牛
Can Bausch + Lomb Corporation stock resist sector downturnsJuly 2025 Big Picture & Technical Buy Zone Confirmations - newser.com
What is the fair value estimate for Bausch + Lomb Corporation (S2L) stock in 20252025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Earnings visualization tools for Bausch + Lomb CorporationJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Does Bausch + Lomb Corporation (S2L) stock trade below intrinsic value2025 Fundamental Recap & Reliable Intraday Trade Alerts - newser.com
Wells Fargo Maintains Bausch + Lomb (BLCO) Equal-Weight Recommendation - Nasdaq
Jefferies raises Bausch & Lomb stock price target to $20 on strong growth outlook - Investing.com Nigeria
Bausch & Lomb stock price target raised to $19 by RBC on margin outlook - Investing.com South Africa
Custom strategy builders for tracking Bausch + Lomb CorporationJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Cautious Hold Rating on Bausch + Lomb: Awaiting Catalysts for Stock Valuation Boost - TipRanks
Short interest data insights for Bausch + Lomb CorporationJuly 2025 Institutional & Weekly Top Performers Watchlists - newser.com
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $13 to $19 - 富途牛牛
RBC Raises Price Target on Bausch + Lomb to $19 From $17, Keeps Outperform Rating - MarketScreener
Needham maintains Hold rating on Bausch & Lomb stock amid pipeline potential - Investing.com UK
How strong is Bausch + Lomb Corporation stock revenue growth2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Using data models to predict Bausch + Lomb Corporation stock movementMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Why Bausch + Lomb Corporation stock could see breakout soonMarket Sentiment Review & Safe Swing Trade Setup Alerts - newser.com
Bausch + Lomb Sets Ambitious Growth Targets At Investor Day - Finimize
Bausch + Lomb Targets Sales, Profit Growth in 3-Year Plan - 富途牛牛
Bausch + Lomb Brief: Will Unveil Plans to Achieve "Above-market revenue growth and meaningful margin expansion" - MarketScreener
Bausch + Lomb Brief: Said To Highlight Company "Transformation And Growth Strategy" At Investor Day Today - MarketScreener
Bausch + Lomb sets 5-7% revenue growth target through 2028 By Investing.com - Investing.com South Africa
Bausch + Lomb Unveils Strategic Growth Plan at Investor Day - TipRanks
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day - The Joplin Globe
New Eye Tech Is Booming For Alcon, Stock Soars - Benzinga
(BLCO) Trading Advice (BLCO:CA) - news.stocktradersdaily.com
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsInsider Selling & Verified Entry Point Signals - newser.com
What margin trends mean for Bausch + Lomb Corporation stockCPI Data & Weekly Breakout Watchlists - newser.com
Stocks in play: Bausch + Lomb Corporation - The Globe and Mail
Bausch + Lomb (NYSE: BLCO) ONE by ONE Recycling totals 691,180 lbs, 114,037,136 units - Stock Titan
Bausch Lomb Corp Stock (BLCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):